← Leaderboards
Jeff Douglas Williamson
Wake Forest University Health Sciences
$16,761,474
Attributed
$30,447,398
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $22.5M · FY2008–25$25M$18.8M$12.5M$6.3M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$114,436,950 · 14
By mechanism
U19$83,989,552 · 1
R01$9,933,956 · 1
P30$6,702,422 · 4
R33$6,046,063 · 1
U24$5,472,632 · 1
U10$1,334,276 · 1
Top collaborators
- Karen P Alexander6 shared
- Walter T Ambrosius6 shared
- Jiang He6 shared
- Adrian Hernandez6 shared
- Katherine Teresa Mills6 shared
- David M Reboussin5 shared
- Nicole R. Fowler3 shared
- Thomas K Karikari3 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Suzanne Craft$45,089,134
- Timothy M. Hughes$16,768,866
- Christopher T Whitlow$19,734,554
- Hariom Yadav$5,459,448
- Tina E Brinkley$10,719,519
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposFundingParticipantElderlyResearch PersonnelClinical ResearchResourcesCognitiveDementiaClinical TrialsInnovationLeadershipEnsureDesignPreventPathway InteractionsImpaired CognitionPreventionImageForestRecruitProgramsAffectAdult
Grant awards (45)
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)$10,487,354
U19 · FY2025 · AG
Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network$1,787,678
U24 · FY2025 · AG
Clinical Core$779,002
P30 · FY2025 · AG · contact PI
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)$13,319,036
U19 · FY2024 · AG
Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network$1,800,259
U24 · FY2024 · AG
Effectiveness of Implementing an Intensive Blood Pressure Reduction Intervention on Cognitive Decline in Low-income and Minority Hypertensive Patients$1,404,371
R33 · FY2024 · AG
Clinical Core$779,002
P30 · FY2024 · AG · contact PI
Evidence to Impact: Accelerating Implementation of Aging Research$47,441
R13 · FY2024 · AG
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)$15,644,347
U19 · FY2023 · AG
Alzheimer Diagnosis in older Adults with Chronic Conditions ADACC Network$1,884,695
U24 · FY2023 · AG
Effectiveness of Implementing an Intensive Blood Pressure Reduction Intervention on Cognitive Decline in Low-income and Minority Hypertensive Patients$1,621,602
R33 · FY2023 · AG
Clinical Core$779,002
P30 · FY2023 · AG · contact PI
SPRINT MIND 2020$721,444
R01 · FY2023 · AG
Evidence to Impact: Accelerating Implementation of Aging Research$47,441
R13 · FY2023 · AG
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)$18,482,472
U19 · FY2022 · AG
SPRINT MIND 2020$1,360,139
R01 · FY2022 · AG
Effectiveness of Implementing an Intensive Blood Pressure Reduction Intervention on Cognitive Decline in Low-income and Minority Hypertensive Patients$1,295,650
R33 · FY2022 · AG
Clinical Core$779,002
P30 · FY2022 · AG · contact PI
Administrative Supplement: Effectiveness of Implementing an Intensive Blood Pressure Reduction Intervention on Cognitive Decline in Low-income and Minority Hypertensive Patients$414,148
R33 · FY2022 · AG
Clinical Research Core (CRC)$168,742
P30 · FY2022 · AG · contact PI
Evidence to Impact: Accelerating Implementation of Aging Research$48,451
R13 · FY2022 · AG
SPRINT MIND 2020$1,404,351
R01 · FY2021 · AG
Effectiveness of Implementing an Intensive Blood Pressure Reduction Intervention on Cognitive Decline in Low-income and Minority Hypertensive Patients$1,310,292
R33 · FY2021 · AG
Clinical Core$779,002
P30 · FY2021 · AG · contact PI
Clinical Research Core (CRC)$162,242
P30 · FY2021 · AG · contact PI
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)$15,392,504
U19 · FY2020 · AG
SPRINT MIND 2020$1,524,532
R01 · FY2020 · AG
Effectiveness of Implementing an Intensive Blood Pressure Reduction Intervention on Cognitive Decline in Low-income and Minority Hypertensive Patients$768,145
R61 · FY2020 · AG
Core B: Clinical Core$545,084
P30 · FY2020 · AG · contact PI
Clinical Research Core (CRC)$157,183
P30 · FY2020 · AG · contact PI
PRagmatic EValuation of evENTs And Benefits of Lipid-lowering in oldEr Adults (PREVENTABLE)$10,663,839
U19 · FY2019 · AG
Core B: Clinical Core$549,954
P30 · FY2019 · AG · contact PI
Clinical Research Core (CRC)$198,405
P30 · FY2019 · AG · contact PI
Clinical Research Core (CRC)$214,410
P30 · FY2018 · AG · contact PI
The SPRINT Alzheimer's, Seniors and Kidney Study (SPRINT ASK)$4,923,490
R01 · FY2017 · AG
Wake Forest Data Coordinating Core$87,958
U10 · FY2017 · AA · contact PI
Wake Forest Data Coordinating Core$1,246,318
U10 · FY2016 · AA · contact PI
CLINICAL RESEARCH CORE$191,178
P30 · FY2012 · AG · contact PI
CLINICAL RESEARCH CORE$192,305
P30 · FY2011 · AG · contact PI
CLINICAL RESEARCH CORE$68,191
P30 · FY2010 · AG · contact PI
CLINICAL RESEARCH CORE$175,228
P30 · FY2009 · AG · contact PI
ALZHEIMER'S DISEASE NEUROIMAGING NETWORK (ADNI)$15,086
M01 · FY2009 · RR · contact PI
CLINICAL RESEARCH CORE$184,490
P30 · FY2008 · AG · contact PI
ALZHEIMER'S DISEASE NEUROIMAGING NETWORK (ADNI)$30,452
M01 · FY2008 · RR · contact PI
ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES - MEMORY IN DIABETES MRI$1,033
M01 · FY2008 · RR · contact PI